No headlines found.
Novanta to Present at the William Blair 44th Annual Growth Stock Conference on Tuesday, June 4, 2024
Business Wire (Fri, 19-Apr 3:48 PM ET)
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, May 7, 2024
Business Wire (Tue, 9-Apr 5:00 PM ET)
Politan Nominates Two Independent Candidates for Masimo Board
Business Wire (Mon, 25-Mar 7:00 AM ET)
Novanta Announces Financial Results for the Fourth Quarter and Full Year 2023
Business Wire (Wed, 28-Feb 6:59 AM ET)
Novanta Inc. Schedules Earnings Release and Conference Call for Wednesday, February 28, 2024
Business Wire (Mon, 29-Jan 5:00 PM ET)
Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.
Novanta - Common Shares trades on the NASDAQ stock market under the symbol NOVT.
As of April 25, 2024, NOVT stock price declined to $155.79 with 4,781 million shares trading.
NOVT has a beta of 2.12, meaning it tends to be more sensitive to market movements. NOVT has a correlation of 0.40 to the broad based SPY ETF.
NOVT has a market cap of $5.58 billion. This is considered a Mid Cap stock.
Last quarter Novanta - Common Shares reported $212 million in Revenue and $.63 earnings per share. This beat revenue expectation by $879,000 and met earnings estimates .
In the last 3 years, NOVT stock traded as high as $187.61 and as low as $110.84.
The top ETF exchange traded funds that NOVT belongs to (by Net Assets): VTI, IJH, VB, IWM, VXF.
NOVT has underperformed the market in the last year with a price return of -1.7% while the SPY ETF gained +22.7%. NOVT has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -1.6% and -4.9%, respectively, while the SPY returned +3.2% and -2.9%, respectively.
NOVT support price is $154.01 and resistance is $161.61 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NOVT stock will trade within this expected range on the day.